Secondary hemochromatosis
Common Name(s)
Secondary hemochromatosis
Advocacy and Support Organizations
Condition Specific Organizations
Following organizations serve the condition "Secondary hemochromatosis" for support, advocacy or research.
The mission of the American Hemochromatosis Society (AHS) is to educate and support the victims of HFE-associated hereditary hemochromatosis (genetic iron overload) and their families as well as educate the medical community on the latest research on Hereditary Hemochromatosis (HH). AHS' aim is to identify through genetic testing, the 43 million+ Americans who unknowingly carry the single or double gene mutations for HH which puts them at risk for loading excess iron.
Our vision is that no Australian should suffer harm from haemochromatosis. As the primary support and advocacy group for Australians affected by haemochromatosis, we provide support and promote awareness, early diagnosis and research.
Reducing pain, suffering and unnecessary death due to disorders of iron through awareness, education and research.
How do you compare to others with this condition?
Privately answer questions about your health. Let resources, you select, come to you.
Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.
Advocacy and Support Organizations
Condition Specific Organizations
Following organizations serve the condition "Secondary hemochromatosis" for support, advocacy or research.
The mission of the American Hemochromatosis Society (AHS) is to educate and support the victims of HFE-associated hereditary hemochromatosis (genetic iron overload) and their families as well as educate the medical community on the latest research on Hereditary Hemochromatosis (HH). AHS' aim is to identify through genetic testing, the 43 million+ Americans who unknowingly carry the single or double gene mutations for HH which puts them at risk for loading excess iron.
http://www.americanhs.org Our vision is that no Australian should suffer harm from haemochromatosis. As the primary support and advocacy group for Australians affected by haemochromatosis, we provide support and promote awareness, early diagnosis and research.
http://www.haemochromatosis.org.au Reducing pain, suffering and unnecessary death due to disorders of iron through awareness, education and research.
http://www.irondisorders.orgRecommended Apps
Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.
Finding the right clinical trial for Secondary hemochromatosis can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.
Scientific Literature
Articles from the PubMed Database
Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Secondary hemochromatosis" returned 7 free, full-text research articles on human participants.
First 3 results:
Journal: J Microbiol Immunol Infect. 2010 Feb;43(1):77-80.
Trichosporon asahii (formerly known as T. beigelii) is an emerging, life-threatening opportunistic pathogen, especially in severely granulocytopenic patients with underlying hematological malignancies. Other reported predisposing factors for infection with this pathogen include organ ...
Journal: J. Korean Med. Sci.. 2008 Apr;23(2):320-3.
A 16-yr-old male patient with hemochromatosis due to multiple packed red blood cell transfusions was referred to our emergency center for the treatment of severe aplastic anemia and dyspnea. He was diagnosed with aplastic anemia at 11-yr of age. He had received continuous transfusions ...
Journal: Intern. Med.. 2008 ;47(6):515-20.
A 30-year-old normocalcemic man with hypopituitarism, hypogonadism, diabetes mellitus, and secondary hemochromatosis due to multiple blood transfusions was admitted because of adrenal crisis. After intravenous administration of saline and cortisol, the corrected serum level of calcium ...
To view other free, full-text articles on human participants, please click on the link below.
Reviews from the PubMed Database
Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Secondary hemochromatosis" returned 1 free, full-text review articles on human participants.
First 3 results:
Journal: Dtsch Arztebl Int. 2009 Jul;106(30):499-504, I.
Because secondary hemochromatosis is due to hereditary or acquired anemia, phlebotomy is not a suitable means of removing excess iron in this situation. Rather, the treatment is based on the targeted elimination of iron by means of iron chelators.
To view other free, full-text review articles on human participants, please click on the link below.
Symptoms, Diagnosis, and Treatment
https://ghr.nlm.nih.gov/condition/hypomagnesemia-with-secondary-hypocalcemia
https://ghr.nlm.nih.gov/gene/HFE
https://ghr.nlm.nih.gov/condition/african-iron-overload
https://ghr.nlm.nih.gov/gene/HAMP
https://ghr.nlm.nih.gov/primer/secondaryfindings
https://ghr.nlm.nih.gov/gene/TFR2
https://ghr.nlm.nih.gov/gene/HJV
https://ghr.nlm.nih.gov/condition/raynaud-phenomenon
https://ghr.nlm.nih.gov/gene/FAAH
https://ghr.nlm.nih.gov/gene/SLC40A1
https://ghr.nlm.nih.gov/gene/ADCY3
https://ghr.nlm.nih.gov/gene/ATP6AP2
https://ghr.nlm.nih.gov/gene/DDX58
https://ghr.nlm.nih.gov/gene/FOXO3
https://ghr.nlm.nih.gov/gene/PUS1
https://ghr.nlm.nih.gov/gene/SERPIND1
https://ghr.nlm.nih.gov/gene/LTA
https://ghr.nlm.nih.gov/condition/bartter-syndrome
https://ghr.nlm.nih.gov/condition/5-alpha-reductase-deficiency
There are currently no related results available in GeneReviews.
There are currently no related results available in Genetic Testing Registry.
Clinical Trial Information This information is provided by ClinicalTrials.gov
There are currently no open clinical trials for this condition.
Finding the right clinical trial for Secondary hemochromatosis can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.